Published in Clin Microbiol Infect on May 07, 2012
Clostridium difficile isolates with high linezolid MICs harbor the multiresistance gene cfr. Antimicrob Agents Chemother (2014) 1.08
Epidemiology of Clostridium difficile infection and risk factors for unfavorable clinical outcomes: results of a hospital-based study in Barcelona, Spain. J Clin Microbiol (2013) 0.92
Impact of clinical awareness and diagnostic tests on the underdiagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis (2015) 0.84
Doxycycline and Tigecycline: Two Friendly Drugs with a Low Association with Clostridium Difficile Infection. Antibiotics (Basel) (2015) 0.81
Epidemiology and Risk Factors for Community-Associated Clostridium difficile Infection: A Narrative Review. Infect Dis Ther (2016) 0.78
Pseudomembranous colitis associated with a triple therapy for Helicobacter pylori eradication. World J Gastroenterol (2013) 0.78
Current knowledge on the laboratory diagnosis of Clostridium difficile infection. World J Gastroenterol (2017) 0.75
Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID). Eur J Clin Microbiol Infect Dis (2016) 0.75
The emergence of Clostridium difficile PCR-ribotype 001 in Slovakia. Eur J Clin Microbiol Infect Dis (2015) 0.75
The emergence of Clostridium difficile infection in Asia: A systematic review and meta-analysis of incidence and impact. PLoS One (2017) 0.75
Point-prevalence survey of healthcare facility-onset healthcare-associated Clostridium difficile infection in Greek hospitals outside the intensive care unit: The C. DEFINE study. PLoS One (2017) 0.75
Age and gender differences in Clostridium difficile-related hospitalization trends in Madrid (Spain) over a 12-year period. Eur J Clin Microbiol Infect Dis (2016) 0.75
Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med (1992) 8.15
A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian Collaborative Ritonavir Study Group. N Engl J Med (1995) 3.04
Surgically treated perforations of the gastrointestinal tract caused by ingested foreign bodies. Colorectal Dis (2007) 2.60
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect (2011) 2.38
Comparative study of mupirocin and oral co-trimoxazole plus topical fusidic acid in eradication of nasal carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1995) 2.14
Pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: incidence, risk factors, and outcome. Clin Microbiol Infect (2009) 2.13
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrob Agents Chemother (2007) 2.04
[Antimicrobial therapy in exacerbated chronic obstructive pulmonary disease]. Arch Bronconeumol (2002) 2.03
Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin. Antimicrob Agents Chemother (2002) 2.00
Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine (Baltimore) (2001) 2.00
Visceral leishmaniasis in immunocompromised hosts. Am J Med (1987) 1.99
Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV). Ann Intern Med (1989) 1.82
Evolution of susceptibilities of Campylobacter spp. to quinolones and macrolides. Antimicrob Agents Chemother (1994) 1.78
Evaluation of a new system, VITEK 2, for identification and antimicrobial susceptibility testing of enterococci. J Clin Microbiol (2000) 1.78
Efficacy of aminocaproic, tranexamic acids in the control of bleeding during total knee replacement: a randomized clinical trial. Br J Anaesth (2006) 1.75
Multiply antibiotic-resistant Streptococcus pneumoniae recovered from Spanish hospitals (1988-1994): novel major clones of serotypes 14, 19F and 15F. Microbiology (1996) 1.69
Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med (1993) 1.69
Gram-negative prosthetic joint infection: outcome of a debridement, antibiotics and implant retention approach. A large multicentre study. Clin Microbiol Infect (2014) 1.61
Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Ann Surg Oncol (2003) 1.60
Evaluation of the upgraded amplified Mycobacterium tuberculosis direct test (gen-probe) for direct detection of Mycobacterium tuberculosis in respiratory and non-respiratory specimens. Diagn Microbiol Infect Dis (2001) 1.60
Evaluation of the MB/BacT mycobacterium detection system for susceptibility testing of Mycobacterium tuberculosis. J Clin Microbiol (2000) 1.59
Failure of ciprofloxacin therapy for invasive nontyphoidal salmonellosis. Clin Infect Dis (1998) 1.59
Klebsiella bacteremia: an analysis of 100 episodes. Rev Infect Dis (1985) 1.56
Thalidomide in patients with acquired immunodeficiency syndrome. Arch Intern Med (1992) 1.56
Bloodstream infections in patients with kidney disease: risk factors for poor outcome and mortality. J Hosp Infect (2013) 1.55
Free radical scavenger and antihepatotoxic activity of Rosmarinus tomentosus. Planta Med (1993) 1.54
Yersinia enterocolitica Septicemia. Am J Clin Pathol (1980) 1.54
Linkage among isozyme, RFLP and RAPD markers in Vicia faba. Theor Appl Genet (1993) 1.51
"Second-look" cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD. J Hosp Infect (2001) 1.49
Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J Clin Microbiol (2008) 1.49
[Spanish public opinion concerning organ donation and transplantation]. Med Clin (Barc) (1995) 1.48
Double-balloon enteroscopy: a descriptive study of 50 explorations. Rev Esp Enferm Dig (2006) 1.41
Influence of different natural zeolite concentrations on the anaerobic digestion of piggery waste. Bioresour Technol (2001) 1.41
Candida infective endocarditis. Eur J Clin Microbiol Infect Dis (2008) 1.41
[Neoplasms associated with human immunodeficiency virus infection. Study of the clinical course of 70 patients]. Med Clin (Barc) (1993) 1.39
In vitro activity of linezolid against multiply resistant Gram-positive clinical isolates. J Antimicrob Chemother (2001) 1.38
Metronidazole resistance in Clostridium difficile is heterogeneous. J Clin Microbiol (2008) 1.38
[Mills' syndrome secondary to hypoplasia of the basilar artery]. Neurologia (1990) 1.38
Role of universal 16S rRNA gene PCR and sequencing in diagnosis of prosthetic joint infection. J Clin Microbiol (2011) 1.37
A conservative procedure for the diagnosis of catheter-related infections. Arch Intern Med (1990) 1.36
Susceptibility of Streptococcus pneumoniae to penicillin: a prospective microbiological and clinical study. Clin Infect Dis (1992) 1.34
[Use of antibiotics in exacerbated chronic obstructive pulmonary disease]. Aten Primaria (2001) 1.31
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain. Antimicrob Agents Chemother (2007) 1.28
Infections in hairy-cell leukemia. Blood (1978) 1.26
Successful outcome of Scedosporium apiospermum disseminated infection treated with voriconazole in a patient receiving corticosteroid therapy. Clin Infect Dis (2000) 1.23
Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect (2010) 1.23
Group-C beta-hemolytic streptococcal bacteremia. Diagn Microbiol Infect Dis (1992) 1.22
Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. Antimicrob Agents Chemother (2001) 1.22
Group G streptococcal endocarditis. Am J Clin Pathol (1978) 1.22
Infectious osteitis pubis. Urology (1978) 1.22
Population-based survey of filamentous fungi and antifungal resistance in Spain (FILPOP Study). Antimicrob Agents Chemother (2013) 1.22
Similarities and differences in RANTES- and (AOP)-RANTES-triggered signals: implications for chemotaxis. J Cell Biol (1999) 1.20
Multicenter study of isavuconazole MIC distributions and epidemiological cutoff values for Aspergillus spp. for the CLSI M38-A2 broth microdilution method. Antimicrob Agents Chemother (2013) 1.20
Leuconostoc species as a cause of bacteremia: two case reports and a literature review. Eur J Clin Microbiol Infect Dis (1991) 1.17
Rapid detection of toxigenic Clostridium difficile from stool samples by a nested PCR of toxin B gene. J Hosp Infect (1999) 1.17
Nasal carriage of S. aureus increases the risk of surgical site infection after major heart surgery. J Hosp Infect (2007) 1.17
Group A streptococcal bacteremia. A 10-year prospective study. Medicine (Baltimore) (1997) 1.16
Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma. Leukemia (2011) 1.16
In vitro activity of the new glycopeptide LY333328 against multiply resistant gram-positive clinical isolates. Antimicrob Agents Chemother (1998) 1.15
Rhodococcus equi infection in transplant recipients: case report and review of the literature. Transplantation (1998) 1.14
Lemierre's disease: postanginal bacteremia and pulmonary involvement caused by Fusobacterium necrophorum. Rev Infect Dis (1989) 1.12
Organ donation and family decision-making within the Spanish donation system. Soc Sci Med (2001) 1.12
Workload due to Aspergillus fumigatus and significance of the organism in the microbiology laboratory of a general hospital. J Clin Microbiol (2005) 1.11
Group B Streptococcus: a cause of urinary tract infection in nonpregnant adults. Clin Infect Dis (1992) 1.11
Molecular analysis of relapse vs re-infection in HIV-positive patients suffering from recurrent Clostridium difficile associated diarrhoea. J Hosp Infect (2001) 1.11
Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin Microbiol Infect (2004) 1.09
Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: the impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics. The Spanish Surveillance Group for Respiratory Pathogens. J Antimicrob Chemother (2000) 1.09
Antifungal susceptibility of 596 Aspergillus fumigatus strains isolated from outdoor air, hospital air, and clinical samples: analysis by site of isolation. Antimicrob Agents Chemother (2005) 1.09
Pneumonia treated in the internal medicine department: focus on healthcare-associated pneumonia. Clin Microbiol Infect (2012) 1.09
True absorption and retention of supplemental iron is more efficient when iron is administered every three days rather than daily to iron-normal and iron-deficient rats. J Nutr (1995) 1.08
Coccidioidal meningitis. An analysis of thirty-one cases and review of the literature. Medicine (Baltimore) (1981) 1.07
In vitro activities of six fluoroquinolones against 250 clinical isolates of Mycobacterium tuberculosis susceptible or resistant to first-line antituberculosis drugs. Antimicrob Agents Chemother (2000) 1.06
Identification of QTLs influencing agronomic traits in Miscanthus sinensis Anderss. I. Total height, flag-leaf height and stem diameter. Theor Appl Genet (2003) 1.06
Postsurgical mediastinitis: a case-control study. Clin Infect Dis (1997) 1.06
Extra-intestinal infections caused by Clostridium difficile. Clin Microbiol Infect (2001) 1.06
Abdominal wall endometriosis in absence of previous surgery. J Ultrasound Med (1999) 1.05
Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Spain: a multicentre prevalence study (2002). Clin Microbiol Infect (2007) 1.05
Listeriosis in patients infected with human immunodeficiency virus. Rev Infect Dis (1991) 1.05
In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole. Antimicrob Agents Chemother (2005) 1.03
Evidence of nosocomial Stenotrophomonas maltophilia cross-infection in a neonatology unit analyzed by three molecular typing methods. Infect Control Hosp Epidemiol (1999) 1.03